N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. - Wikidata - awgldk - TriplyDB

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

http://www.wikidata.org/entity/Q40672731

about

International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system Physiology and pharmacology of the vanilloid receptor Orphan endogenous lipids and orphan GPCRs: a good match Novel delivery strategies for glioblastoma TRP channels and analgesia The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons TRPV1: A Potential Drug Target for Treating Various Diseases.Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.Transient receptor potential (TRP) channels: a clinical perspective N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine.A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development.Are sensory TRP channels biological alarms for lipid peroxidation?Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels.The expanding field of cannabimimetic and related lipid mediators.Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation.Potentiation of TRPV3 channel function by unsaturated fatty acids.Capsaicin induces NKCC1 internalization and inhibits chloride secretion in colonic epithelial cells independently of TRPV1.TRPV1 antagonists elevate cell surface populations of receptor protein and exacerbate TRPV1-mediated toxicities in human lung epithelial cells Targeted lipidomics: discovery of new fatty acyl amides The emerging role of TRP channels in mechanisms of temperature and pain sensation N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.The complications of promiscuity: endocannabinoid action and metabolism Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors.ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1 Biosynthesis, degradation and pharmacological importance of the fatty acid amides Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?Inflammatory pain: the cellular basis of heat hyperalgesia.Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.Identification of endogenous acyl amino acids based on a targeted lipidomics approach.Identification of an arylalkylamine N-acyltransferase from Drosophila melanogaster that catalyzes the formation of long-chain N-acylserotonins.

P2860

Q24623493-DA20D910-A2BF-49B9-96F2-2AE37DDB2206 Q24627020-8A1C723C-1A8C-4145-9748-46CB3823B503 Q24653664-0CB73D1D-9577-4EED-B205-BE7D21A5F563 Q24657799-95D372B2-D12E-4DA8-96C8-AE6F1045538E Q27006099-8BBCFB37-9317-4EF7-9FCF-9B938E58D601 Q27021608-E7DD4C4C-E955-4D5A-970F-462424B3DB67 Q28236199-C48D571B-CD39-46F1-A31E-6762BE19C4F7 Q28242911-293617AD-409C-4ACA-AE04-45CC2F0D07AB Q28271125-43B1F2A0-4000-4951-9489-7DE4ACC87332 Q28272440-EBEF2773-5FD9-44B4-9153-FF1E145B53BB Q30434994-4DABBBE5-7249-4703-B131-906DC98FD298 Q33410345-20D74BD8-D26A-4A96-A92C-8FA3BC19C563 Q33562143-6E51F772-A8F4-4D4A-829A-5DE0A6B13728 Q33670471-BFAF0C03-06F4-4DED-94DF-1149B2E1FD01 Q33901801-5E91A1B3-8C80-4DEE-8778-1890BD9B6FE5 Q34114130-75D9F10A-E9E1-4219-AFF3-4A7D2C76EF8B Q34205553-334D8E86-4D0E-462F-BEC7-0FA2EC739ED9 Q34358689-6CFBCAA3-00F0-4E9D-A756-2EF1219BB155 Q34442314-BA65DEF0-F292-4851-AC78-4622087EB258 Q35047139-F4512F65-C79D-4009-85F1-BEB2B5263F23 Q35047663-EDFBA1AB-1EB6-4435-AA9A-61D352AF1F80 Q35048658-98E5CC82-478B-45C7-B63C-2EE4186FD463 Q35227731-2567D7B9-136F-45D9-B6A8-B0ECEDE6FD21 Q35690268-56FB25D4-3C0F-4AF4-97C3-E5A25147F8DC Q36527974-F7AFA5ED-B001-40A7-8B82-A5705301B786 Q36536519-C2C8D60E-5E45-464E-AD53-1173FABCFA84 Q36616306-C03BBB35-9FC8-4981-9466-FF9355F138E1 Q36726641-4DD9FF4B-5016-4672-A719-30746F1F844B Q36844609-12F5A20C-883A-4C08-A228-B5DABD2B8E60 Q36944706-28853620-EF9D-4BEC-A451-612A3AAF2E9F Q37023851-F18EE2C1-62C8-4EC7-A278-720346F9FFCA Q37030016-19FDDF8C-7E02-4DBA-B3E4-FDCF7C5419B0 Q37104144-628E720C-918A-4614-9943-D4DC569CDF16 Q37155833-96D6980F-460D-42F4-9117-1B7827A7699D Q37180517-AC3A036B-21A8-470F-A6D7-7EC0F2C68374 Q37211785-431752ED-2F37-4552-B9BB-5A110D035CCB Q37359261-EFC0EFB7-2AF9-4443-8AA9-856233BA2726 Q37391727-209D05DD-B547-4269-BCA8-C988F627DFBB Q37463247-160625DB-6AB9-47AC-B4E2-C1FAEDFE70FA Q37634445-3FC477A0-8102-4AEB-A23B-E9CAA0C6C154

P2860

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

http://www.wikidata.org/entity/Q40672731

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

@en

type

label

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

@en

prefLabel

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

@en

P1433

Q40672731-94BE485D-811D-4E82-A63D-898B4DED1E66

P1476

Q40672731-1B625FE7-4725-43F4-A352-31ED026FDC37

P2093

Q40672731-1CDC90C0-F303-41AB-89FD-3E2E307198AE

Q40672731-24E2F160-4531-4B6F-9CFD-3A708A8750A8

Q40672731-3494E790-7829-4358-95EA-C6CE5FA77CB3

Q40672731-40894229-8E52-4259-AADD-48DAE75DB72F

Q40672731-4C41A079-4D00-4979-8E6F-08FE5021852F

Q40672731-68F5C139-4315-4225-9DCE-3C01D7E88A2E

Q40672731-74C4E8F8-41F8-4407-8C4D-592B7BCFEE55

Q40672731-A198DC08-9070-4820-BAA8-A0F6742A0860

Q40672731-CF5AB9C1-5BC5-4A8D-AA48-EC220429AB99

P2860

Q40672731-143CF249-81B9-4511-BF0D-B21D261DBBD2

Q40672731-1EED570C-BF95-43E0-993C-CF11F39EBD9A

Q40672731-2178CA6B-963F-48E9-A452-2CDE5FA66104

Q40672731-45DB7439-2EA4-4A15-BE76-CD6D4050E19C

Q40672731-4A3766A8-3B80-44E9-B21B-C1E171BDBA84

Q40672731-4CF1D9A9-84B7-4C7B-98B8-529938AB45E3

Q40672731-507AD403-6904-4779-8A1F-9F1656217728

Q40672731-52137F21-9200-405B-9323-42178525C803

Q40672731-58D37B30-17FD-42A1-B870-2CA57915D7AA

Q40672731-5A9FCCBC-D20F-4CCC-B0D3-69F2D729673A

P304

Q40672731-5873E039-1163-4726-98D4-3E72B42408C5

P31

Q40672731-B8F9D604-97E7-4552-8469-590103DCAB20

P356

Q40672731-D32001CD-C97E-47E4-B224-AD76F708778A

P407

Q40672731-1FE703E3-B80F-4CC3-8EB3-B20A8FFCF78A

P433

Q40672731-7DD1A72D-E669-4782-91BC-7A1C78D3FA1F

P478

Q40672731-FC9A7C76-9B14-4733-91DF-85C2F63C65FE

P50

Q40672731-09CA7BDE-3517-478D-BF8A-28ED8103F3B9

Q40672731-47682F9C-2C90-422C-88D5-FF9FE3015F39

P577

Q40672731-EACB7010-343F-42E9-BC70-624637A2464E

P698

Q40672731-B23F3BE1-7D30-4EC5-B756-4B3D031D0E90

P921

Q40672731-ED088508-1EB6-4EDD-AE2A-36B35851B25B

P356

P1433

Journal of Biological Chemistry

P1476

N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.

@en

P2093

Constance J Chu

http://www.w3.org/2001/XMLSchema#string

J Michael Walker

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Miller

http://www.w3.org/2001/XMLSchema#string

Luciano De Petrocellis

http://www.w3.org/2001/XMLSchema#string

Nives Daddario

http://www.w3.org/2001/XMLSchema#string

Robert E Zipkin

http://www.w3.org/2001/XMLSchema#string

Scott A Ewing

http://www.w3.org/2001/XMLSchema#string

Susan M Huang

http://www.w3.org/2001/XMLSchema#string

Tiziana Bisogno

http://www.w3.org/2001/XMLSchema#string

P2860

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

P304

13633-13639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M211231200

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Di Marzo

Giovanni Appendino

P577

2003-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12569099

http://www.w3.org/2001/XMLSchema#string

P921

N-[2-(3,4-dihydroxyphenyl)ethyl]hexadecanamide